These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17506731)

  • 1. Cost effectiveness of adult intensive care in the UK.
    Ridley S; Morris S
    Anaesthesia; 2007 Jun; 62(6):547-54. PubMed ID: 17506731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.
    Davies A; Ridley S; Hutton J; Chinn C; Barber B; Angus DC
    Anaesthesia; 2005 Feb; 60(2):155-62. PubMed ID: 15644013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research.
    Am J Respir Crit Care Med; 2002 Feb; 165(4):540-50. PubMed ID: 11850349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
    Findley LJ; Lees A; Apajasalo M; Pitkänen A; Turunen H
    Curr Med Res Opin; 2005 Jul; 21(7):1005-14. PubMed ID: 16004667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Evaluation of Telemedicine for Patients in ICUs.
    Yoo BK; Kim M; Sasaki T; Melnikow J; Marcin JP
    Crit Care Med; 2016 Feb; 44(2):265-74. PubMed ID: 26540398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incremental cost effectiveness of withdrawing pulmonary artery catheters from routine use in critical care.
    Stevens K; McCabe C; Jones C; Ashcroft J; Harvey S; Rowan K;
    Appl Health Econ Health Policy; 2005; 4(4):257-64. PubMed ID: 16466277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.
    Valentine WJ; Bottomley JM; Palmer AJ; Brändle M; Foos V; Williams R; Dormandy JA; Yates J; Tan MH; Massi-Benedetti M;
    Diabet Med; 2007 Sep; 24(9):982-1002. PubMed ID: 17593245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature.
    Talmor D; Shapiro N; Greenberg D; Stone PW; Neumann PJ
    Crit Care Med; 2006 Nov; 34(11):2738-47. PubMed ID: 16957636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service?
    Palmer S; Sculpher M; Philips Z; Robinson M; Ginnelly L; Bakhai A; Abrams K; Cooper N; Packham C; Alfakih K; Hall A; Gray D
    Int J Cardiol; 2005 Apr; 100(2):229-40. PubMed ID: 15823630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of recombinant activated factor VII for the control of bleeding in patients with severe blunt trauma injuries in the United Kingdom.
    Morris S; Ridley S; Munro V; Christensen MC
    Anaesthesia; 2007 Jan; 62(1):43-52. PubMed ID: 17156226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial.
    Plant PK; Owen JL; Parrott S; Elliott MW
    BMJ; 2003 May; 326(7396):956. PubMed ID: 12727767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin.
    Shorr AF; Susla GM; Kollef MH
    Crit Care Med; 2004 Jan; 32(1):137-43. PubMed ID: 14707572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
    McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
    Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.
    Brennan A; Bansback N; Nixon R; Madan J; Harrison M; Watson K; Symmons D
    Rheumatology (Oxford); 2007 Aug; 46(8):1345-54. PubMed ID: 17562686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
    Wilkinson D; Floyd K; Gilks CF
    S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in the UK.
    Ara RM; Reynolds AV; Conway P
    Rheumatology (Oxford); 2007 Aug; 46(8):1338-44. PubMed ID: 17553909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom.
    Veenstra DL; Sullivan SD; Dusheiko GM; Jacobs M; Aledort JE; Lewis G; Patel KK
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):631-8. PubMed ID: 17625431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.
    Robotham JV; Deeny SR; Fuller C; Hopkins S; Cookson B; Stone S
    Lancet Infect Dis; 2016 Mar; 16(3):348-56. PubMed ID: 26616206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.